07:00 , May 28, 2012 |  BioCentury  |  Product Development

Islet defense

Sernova Corp. is developing its Sertolin cell technology and Cell Pouch System device to provide an immune-privileged, vascularized environment for donor islet cells to produce insulin in insulin-dependent diabetes patients. The approach is intended to...
07:00 , Mar 22, 2012 |  BC Innovations  |  Cover Story

Bioartificial pancreas beta test

Beta-O2 Technologies Ltd. and an international team of academic collaborators have shown that the company's bioartificial pancreas can house donor islets, supply them with oxygen and protect them from the host immune system in vivo...
07:00 , Mar 22, 2012 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms Implantable, bioartificial pancreas for type 1 diabetes An implantable, bioartificial pancreas system could help treat type 1 diabetes. The two-chamber device consists of a module...